Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Breast Cancer Res Treat ; 98(1): 63-70, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16685591

ABSTRACT

Fluid and epithelial cells obtained from the breasts of non-pregnant, non-lactating women by nipple aspiration, can be used for early diagnosis of breast neoplasms. However, since nipple aspirate fluid (NAF) with cells is obtainable from less than half of women sampled, the question arises: Is this method capable of targeting the women most likely to develop breast cancer? We approached this question with a 25-year prospective study to determine if subjects yielding NAF with or without epithelial cells were more likely to develop breast cancer during the follow-up period than subjects from whom no NAF or epithelial cells were obtained. Logistic regression analysis was used to determine relative risk (RR) with 95% confidence intervals (CI). The follow-up cohort of 972 was representative of the eligible cohort of 1605 for factors related to breast cancer risk and nipple aspiration outcome, and representative of the general population for breast cancer risk. After a mean follow-up period of 25 years, women with epithelial cells in NAF were significantly more likely to develop breast cancer (RR=1.92; CI=1.22-3.01; p

Subject(s)
Body Fluids/metabolism , Breast Neoplasms/diagnosis , Breast Neoplasms/metabolism , Epithelial Cells/metabolism , Nipples/pathology , Adolescent , Adult , Aged , Biomarkers, Tumor , Biopsy, Needle , Body Fluids/cytology , Cohort Studies , Female , Humans , Middle Aged , Nipples/metabolism , Prospective Studies , Risk
2.
Endocrinology ; 146(7): 3059-69, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15817668

ABSTRACT

The sodium/iodide symporter (NIS) mediates iodide uptake in lactating breast tissue and is expressed in some breast cancers. We have previously demonstrated that all-trans retinoic acid (tRA) stimulates NIS gene expression and the selective cytotoxic effect of beta-emitting radioiodide-131 ((131)I) in both in vitro and in vivo MCF-7 breast cancer cell systems. We studied the ability of natural and synthetic retinoids, in combination with other nuclear receptor ligands, to achieve greater and more sustained induction of NIS in MCF-7 cells and enhance (131)I-mediated cytotoxicity. Selective stimulation of retinoic acid receptor (RAR) beta/gamma produced marked NIS induction; and selective stimulation of RARalpha, RARgamma, or retinoid X receptor produced more modest induction. Maximal NIS induction was seen with 9-cis retinoic acid and AGN190168, a RAR beta/gamma-agonist. Dexamethasone (Dex), but not the other nuclear receptor ligands, in combination with tRA synergistically induced iodide uptake and NIS mRNA expression, predominantly by prolonging NIS mRNA half-life. The addition of Dex reduced the EC(50) of tRA for NIS stimulation to approximately 7%, such that 10(-7) m tRA with addition of Dex enhanced iodide uptake and selective cytotoxicity of (131)I greater than 10(-6) m tRA alone. AGN190168 combined with Dex synergistically increased iodide uptake and significantly prolonged induction (5 d) of iodide uptake compared with that induced by the combination of tRA/Dex or 9-cis retinoic acid/Dex. The addition of Dex reduced the effective dose of retinoid and prolonged the induction of NIS, especially with AGN190168, suggesting higher efficacy of (131)I after combination treatment.


Subject(s)
Breast Neoplasms/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Symporters/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents, Hormonal/pharmacology , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Line, Tumor , Dexamethasone/administration & dosage , Dexamethasone/pharmacology , Drug Administration Schedule , Drug Combinations , Female , Gene Expression/drug effects , Glucocorticoids/administration & dosage , Glucocorticoids/pharmacology , Humans , Iodides/pharmacokinetics , Iodine Radioisotopes/pharmacology , Ligands , RNA, Messenger/metabolism , Retinoids/administration & dosage , Retinoids/metabolism , Retinoids/pharmacology , Symporters/genetics , Tretinoin/pharmacology , Tumor Stem Cell Assay
3.
Cancer Res ; 64(1): 415-22, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14729653

ABSTRACT

Lactating breast tissue and some breast cancers express the sodium/iodide symporter (NIS) and concentrate iodide. We recently demonstrated that all-trans retinoic acid (tRA) induces both NIS gene expression and iodide accumulation in vitro in well-differentiated human breast cancer cells (MCF-7). In the present study, we investigated the in vivo efficacy and specificity of tRA-stimulated iodide accumulation in mouse breast cancer models. Immunodeficient mice with MCF-7 xenograft tumors were treated with systemic tRA for 5 days. Iodide accumulation in the xenograft tumors was markedly increased, approximately 15-fold greater than levels without treatment, and the effects were tRA dose dependent. Iodide accumulation in other organs was not significantly influenced by tRA treatment. Significant induction of NIS mRNA and protein in the xenograft tumors was observed after tRA treatment. Iodide accumulation and NIS mRNA expression were also selectively induced in breast cancer tissues in transgenic mice expressing the oncogene, polyoma virus middle T antigen. These data demonstrate selective induction of functional NIS in breast cancer by tRA. Treatment with short-term systemic retinoic acid, followed by radioiodide administration, is a potential tool in the diagnosis and treatment of some differentiated breast cancer.


Subject(s)
Breast Neoplasms/drug therapy , Iodine Radioisotopes/pharmacokinetics , Symporters/genetics , Tretinoin/pharmacology , Animals , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic , Humans , Mice , Mice, SCID , Radionuclide Imaging , Symporters/drug effects , Symporters/radiation effects , Tissue Distribution , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...